A global, peer-powered news hub for the psychedelic space — part living archive, part open forum where industry insiders, curious newcomers, and everyone adjacent can share and discuss developments freely. It is uncensored, beginner-welcoming, and built around the collective belief that information should flow without gatekeeping.

A living, uncensored repository for psychedelic news — FDA updates, industry reports, conferences, and breaking stories — all in one place, discussed freely.

Anyone curious about or actively working in the psychedelic space — researchers, clinicians, advocates, journalists, curious newcomers, and everyone in between. You care about staying informed, follow developments in policy, therapy, and culture, and believe information should move freely without censorship or shadowbanning. Many here are industry professionals; others are just beginning their journey and want to learn in the open. Writers find room to publish and be heard. This is a come-as-you-are community built for those who believe the psychedelic conversation — in all its complexity — deserves an honest, living archive.

Open, organic, and contributor-driven — the kind of space where a seasoned clinician and a first-time psychedelic curious person can sit in the same conversation without hierarchy. Dialogue is valued as much as the news itself, and the archive grows richer with every voice added.

A centralized, community-built feed of psychedelic news — FDA decisions, research breakthroughs, policy shifts, conferences, and mainstream coverage — paired with the freedom to discuss, share, and push it further into the world without fear of censorship.